Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas: evidence from a meta-analysis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Hematology"
DOI: 10.1007/s00277-018-3349-y
Abstract: The aim of the present study was to determine whether circulating soluble CD23 (sCD23) was associated with B cells non-Hodgkin’s lymphomas (B-NHL). PubMed, EMBASE, and ISI Web of Science were extensively searched without language restriction.… read more here.
Keywords: analysis; level; soluble cd23; nhl ... See more keywords
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1130052
Abstract: Background Immunotherapy-based regimens have considerably improved the survival rate of B-cell non-Hodgkin lymphoma (B-NHL) patients in the last decades; however, most disease subtypes remain almost incurable. TG-1801, a bispecific antibody that targets CD47 selectively on… read more here.
Keywords: cell; cd20; anti cd20; lymphoma ... See more keywords